Aptargroup, Inc. (ATR)

$146.66

+5.17

(+3.65%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $142.36
    $150.99
    $146.66
    downward going graph

    2.94%

    Downside

    Day's Volatility :5.72%

    Upside

    2.87%

    downward going graph
  • $117.27
    $151.26
    $146.66
    downward going graph

    20.04%

    Downside

    52 Weeks Volatility :22.47%

    Upside

    3.04%

    downward going graph

Returns

PeriodAptargroup, Inc.Sector (Materials)Index (Russel 2000)
3 Months
-1.28%
0.4%
0.0%
6 Months
7.43%
8.9%
0.0%
1 Year
17.96%
5.4%
0.0%
3 Years
3.49%
9.0%
-20.2%

Highlights

Market Capitalization
9.6B
Book Value
$35.48
Dividend Share
1.61
Dividend Yield
1.25%
Earnings Per Share (EPS)
4.66
PE Ratio
30.93
PEG Ratio
3.26
Wall Street Target Price
158.2
Profit Margin
8.83%
Operating Margin TTM
12.7%
Return On Assets TTM
6.74%
Return On Equity TTM
13.92%
Revenue TTM
3.5B
Revenue Per Share TTM
53.85
Quarterly Revenue Growth YOY
6.4%
Gross Profit TTM
1.2B
EBITDA
724.7M
Diluted Eps TTM
4.66
Quarterly Earnings Growth YOY
0.5
EPS Estimate Current Year
5.28
EPS Estimate Next Year
5.79
EPS Estimate Current Quarter
1.15
EPS Estimate Next Quarter
1.36

Analyst Recommendation

Buy
    72%Buy
    27%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for Aptargroup, Inc.(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
7
7
Hold
3
4
4
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 7.87%

Current $146.66
Target $158.20

Company Financials

FY18Y/Y Change
Revenue
2.8B
↑ 11.97%
Net Income
194.7M
↓ 11.49%
Net Profit Margin
7.04%
↓ 1.87%
FY19Y/Y Change
Revenue
2.9B
↑ 3.44%
Net Income
242.2M
↑ 24.37%
Net Profit Margin
8.47%
↑ 1.43%
FY20Y/Y Change
Revenue
2.9B
↑ 2.43%
Net Income
214.0M
↓ 11.63%
Net Profit Margin
7.31%
↓ 1.16%
FY21Y/Y Change
Revenue
3.2B
↑ 10.17%
Net Income
244.1M
↑ 14.04%
Net Profit Margin
7.56%
↑ 0.25%
FY22Y/Y Change
Revenue
3.3B
↑ 2.94%
Net Income
239.3M
↓ 1.97%
Net Profit Margin
7.2%
↓ 0.36%
FY23Y/Y Change
Revenue
3.5B
↑ 4.97%
Net Income
284.5M
↑ 18.89%
Net Profit Margin
8.16%
↑ 0.96%
Q4 FY22Q/Q Change
Revenue
795.9M
↓ 4.89%
Net Income
59.0M
↑ 8.76%
Net Profit Margin
7.41%
↑ 0.93%
Q1 FY23Q/Q Change
Revenue
860.1M
↑ 8.06%
Net Income
54.8M
↓ 7.17%
Net Profit Margin
6.37%
↓ 1.04%
Q2 FY23Q/Q Change
Revenue
895.9M
↑ 4.17%
Net Income
83.1M
↑ 51.69%
Net Profit Margin
9.27%
↑ 2.9%
Q3 FY23Q/Q Change
Revenue
893.0M
↓ 0.32%
Net Income
84.3M
↑ 1.47%
Net Profit Margin
9.44%
↑ 0.17%
Q4 FY23Q/Q Change
Revenue
838.5M
↓ 6.1%
Net Income
62.4M
↓ 26.03%
Net Profit Margin
7.44%
↓ 2.0%
Q1 FY24Q/Q Change
Revenue
915.4M
↑ 9.18%
Net Income
83.1M
↑ 33.28%
Net Profit Margin
9.08%
↑ 1.64%
FY18Y/Y Change
Total Assets
3.4B
↑ 7.59%
Total Liabilities
2.0B
↑ 6.97%
FY19Y/Y Change
Total Assets
3.6B
↑ 5.46%
Total Liabilities
2.0B
↑ 1.79%
FY20Y/Y Change
Total Assets
4.0B
↑ 12.01%
Total Liabilities
2.1B
↑ 7.51%
FY21Y/Y Change
Total Assets
4.1B
↑ 3.79%
Total Liabilities
2.2B
↑ 0.82%
FY22Y/Y Change
Total Assets
4.2B
↑ 1.5%
Total Liabilities
2.1B
↓ 1.0%
FY23Y/Y Change
Total Assets
4.5B
↑ 5.91%
Total Liabilities
2.1B
↓ 0.22%
Q4 FY22Q/Q Change
Total Assets
4.2B
↑ 4.4%
Total Liabilities
2.1B
↓ 0.14%
Q1 FY23Q/Q Change
Total Assets
4.3B
↑ 2.36%
Total Liabilities
2.2B
↑ 1.86%
Q2 FY23Q/Q Change
Total Assets
4.3B
↑ 1.04%
Total Liabilities
2.2B
↓ 0.72%
Q3 FY23Q/Q Change
Total Assets
4.3B
↓ 1.14%
Total Liabilities
2.1B
↓ 3.46%
Q4 FY23Q/Q Change
Total Assets
4.5B
↑ 3.58%
Total Liabilities
2.1B
↑ 2.21%
Q1 FY24Q/Q Change
Total Assets
4.4B
↓ 0.33%
Total Liabilities
2.1B
↓ 2.65%
FY18Y/Y Change
Operating Cash Flow
313.6M
↓ 3.42%
Investing Cash Flow
-735.5M
↑ 227.16%
Financing Cash Flow
-14.9M
↓ 112.96%
FY19Y/Y Change
Operating Cash Flow
514.5M
↑ 64.03%
Investing Cash Flow
-336.3M
↓ 54.28%
Financing Cash Flow
-197.1M
↑ 1225.54%
FY20Y/Y Change
Operating Cash Flow
570.2M
↑ 10.83%
Investing Cash Flow
-452.0M
↑ 34.41%
Financing Cash Flow
-73.7M
↓ 62.6%
FY21Y/Y Change
Operating Cash Flow
363.4M
↓ 36.26%
Investing Cash Flow
-457.2M
↑ 1.16%
Financing Cash Flow
-81.5M
↑ 10.57%
FY22Y/Y Change
Operating Cash Flow
478.6M
↑ 31.69%
Investing Cash Flow
-295.6M
↓ 35.34%
Financing Cash Flow
-162.1M
↑ 98.85%
Q4 FY22Q/Q Change
Operating Cash Flow
172.3M
↑ 32.83%
Investing Cash Flow
-295.6M
↑ 255.02%
Financing Cash Flow
-82.0M
↓ 49.23%
Q1 FY23Q/Q Change
Operating Cash Flow
98.3M
↓ 42.94%
Investing Cash Flow
-89.2M
↓ 69.83%
Financing Cash Flow
-24.8M
↓ 69.71%
Q2 FY23Q/Q Change
Operating Cash Flow
83.9M
↓ 14.66%
Investing Cash Flow
-163.6M
↑ 83.46%
Financing Cash Flow
-11.0M
↓ 55.74%
Q3 FY23Q/Q Change
Operating Cash Flow
173.4M
↑ 106.68%
Investing Cash Flow
-239.3M
↑ 46.29%
Financing Cash Flow
-58.2M
↑ 429.4%

Technicals Summary

Sell

Neutral

Buy

Aptargroup, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Aptargroup, Inc.
Aptargroup, Inc.
-1.54%
7.43%
17.96%
3.49%
13.66%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
-1.32%
16.54%
32.6%
35.62%
148.32%
Resmed Inc.
Resmed Inc.
11.69%
9.57%
-6.0%
-19.79%
64.22%
Becton, Dickinson And Company
Becton, Dickinson And Company
0.5%
-1.64%
-17.69%
-6.68%
-8.49%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-14.37%
-23.3%
-26.95%
-26.58%
102.44%
Alcon Ag
Alcon Ag
2.41%
20.84%
8.21%
30.7%
54.72%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Aptargroup, Inc.
Aptargroup, Inc.
30.93
30.93
3.26
5.28
0.14
0.07
0.01
35.48
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
78.14
78.14
7.13
6.63
0.16
0.08
NA
41.4
Resmed Inc.
Resmed Inc.
32.24
32.24
1.75
7.73
0.22
0.12
0.01
31.52
Becton, Dickinson And Company
Becton, Dickinson And Company
50.71
50.71
1.34
13.04
0.05
0.03
0.02
88.74
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
42.71
42.71
6.72
7.74
0.21
0.11
0.0
36.72
Alcon Ag
Alcon Ag
44.05
44.05
4.59
3.07
0.05
0.02
0.0
42.13
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Aptargroup, Inc.
Aptargroup, Inc.
Buy
$9.6B
13.66%
30.93
8.83%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$161.3B
148.32%
78.14
27.65%
Resmed Inc.
Resmed Inc.
Buy
$30.8B
64.22%
32.24
20.91%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$68.6B
-8.49%
50.71
6.76%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$23.7B
102.44%
42.71
19.42%
Alcon Ag
Alcon Ag
Buy
$45.8B
54.72%
44.05
10.96%

Insights on Aptargroup, Inc.

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 838.48M → 915.44M (in $), with an average increase of 8.4% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 62.35M → 83.10M (in $), with an average increase of 25.0% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 32.6% return, outperforming this stock by 14.6%

  • Vs ISRG

    In the last 3 years, Intuitive Surgical, Inc. has given 35.6% return, outperforming this stock by 32.1%

Institutional Holdings

  • Vanguard Group Inc

    10.81%

  • BlackRock Inc

    9.21%

  • Morgan Stanley - Brokerage Accounts

    7.56%

  • State Farm Mutual Automobile Ins Co

    7.16%

  • State Street Corporation

    4.49%

  • Victory Capital Management Inc.

    2.52%

Corporate Announcements

  • Aptargroup, Inc. Dividends March,2024

    In the quarter ending March,2024. Aptargroup, Inc. has declared dividend of $0.41

    Read More

Company Information

aptar is a leading global supplier of a broad range of innovative dispensing systems for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food, and beverage markets. aptar is headquartered in crystal lake, illinois, with manufacturing facilities in north america, europe, asia and south america. for more information, visit www.aptar.com.

Organization
Aptargroup, Inc.
Employees
13000
CEO
Mr. Stephan B. Tanda
Industry
Process Industries

Discover More

FAQs